HB
HEMEO BV
Presenting entities
Description
HEMEO is a digital health venture dedicated to improve the outcome of surgical and intensive care patients, reducing bleeding and thrombosis. Our coagulation model can predictive and personalised treatment recommendations. Our first application, HEMEO Vantage is a Clinical Decision Support System (CDSS), fully developed and ready to enter regulatory clinical trial.
Represented by:
- Remi Corlin, CEO
- René van den Ham, CTO
Loading